Calcium-dependent Activator Protein for Secretion 2 (CAPS2) Promotes BDNF Secretion and is Critical for the Development of GABAergic Interneuron Network
Overview
Authors
Affiliations
Calcium-dependent activator protein for secretion 2 (CAPS2) is a dense-core vesicle-associated protein that is involved in the secretion of BDNF. BDNF has a pivotal role in neuronal survival and development, including the development of inhibitory neurons and their circuits. However, how CAPS2 affects BDNF secretion and its biological significance in inhibitory neurons are largely unknown. Here we reveal the role of CAPS2 in the regulated secretion of BDNF and show the effect of CAPS2 on the development of hippocampal GABAergic systems. We show that CAPS2 is colocalized with BDNF, both synaptically and extrasynaptically in axons of hippocampal neurons. Overexpression of exogenous CAPS2 in hippocampal neurons of CAPS2-KO mice enhanced depolarization-induced BDNF exocytosis events in terms of kinetics, frequency, and amplitude. We also show that in the CAPS2-KO hippocampus, BDNF secretion is reduced, and GABAergic systems are impaired, including a decreased number of GABAergic neurons and their synapses, a decreased number of synaptic vesicles in inhibitory synapses, and a reduced frequency and amplitude of miniature inhibitory postsynaptic currents. Conversely, excitatory neurons in the CAPS2-KO hippocampus were largely unaffected with respect to field excitatory postsynaptic potentials, miniature excitatory postsynaptic currents, and synapse number and morphology. Moreover, CAPS2-KO mice exhibited several GABA system-associated deficits, including reduced late-phase long-term potentiation at CA3-CA1 synapses, decreased hippocampal theta oscillation frequency, and increased anxiety-like behavior. Collectively, these results suggest that CAPS2 promotes activity-dependent BDNF secretion during the postnatal period that is critical for the development of hippocampal GABAergic networks.
snPATHO-seq, a versatile FFPE single-nucleus RNA sequencing method to unlock pathology archives.
Wang T, Roach M, Harvey K, Morlanes J, Kiedik B, Al-Eryani G Commun Biol. 2024; 7(1):1340.
PMID: 39414943 PMC: 11484811. DOI: 10.1038/s42003-024-07043-2.
Iguchi H, Katsuzawa T, Saruta C, Sadakata T, Kobayashi S, Sato Y Front Mol Neurosci. 2024; 17:1444629.
PMID: 39092202 PMC: 11291307. DOI: 10.3389/fnmol.2024.1444629.
Mechanisms of neuromodulatory volume transmission.
Ozcete O, Banerjee A, Kaeser P Mol Psychiatry. 2024; 29(11):3680-3693.
PMID: 38789677 PMC: 11540752. DOI: 10.1038/s41380-024-02608-3.
Koppensteiner P, Bhandari P, Onal C, Borges-Merjane C, Le Monnier E, Roy U Proc Natl Acad Sci U S A. 2024; 121(8):e2301449121.
PMID: 38346189 PMC: 10895368. DOI: 10.1073/pnas.2301449121.
Zhang F, Chen J, Li Y, Ye J, Wang C Int J Mol Sci. 2023; 24(23).
PMID: 38069318 PMC: 10707181. DOI: 10.3390/ijms242316993.